Biblio Discovery — Demo Discovery Service

5 results for "Adrian Frick"

Showing 1–5 · 7.05 seconds · RSS

  1. Journal Article

    A Novel PAK1–Notch1 Axis Regulates Crypt Homeostasis in Intestinal InflammationSummary

    Adrian Frick; Vineeta Khare; Kristine Jimenez et al.

    Cellular and Molecular Gastroenterology and Hepatology, Vol. 11 No. 3 · 2021 · English · DOAJ Scopus

    Background & Aims: p21-activated kinase-1 (PAK1) belongs to a family of serine-threonine kinases and contributes to cellular pathways such as nuclear factor-κB (NF-κB), mitogen-activated protein kinase (MAPK), phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT), and Wingless-related…

  2. Journal Article Full text

    Study protocol: Fecal Microbiota Transplant combined with Atezolizumab/Bevacizumab in Patients with Hepatocellular Carcinoma who failed to achieve or maintain objective response to Atezolizumab/Bevacizumab – the FAB-HCC pilot study

    Katharina Pomej; Adrian Frick; Bernhard Scheiner et al.

    PLOS ONE, Vol. 20 No. 4 · 2025 · English · PLOS Scopus

    Background: The gut microbiota is often altered in chronic liver diseases and hepatocellular carcinoma (HCC), and increasing evidence suggests that it may influence response to cancer immunotherapy. Strategies to modulate the gut microbiome (i.e., fecal microbiota transplant (FMT)) may help to…

  3. Journal Article

    The food additive EDTA aggravates colitis and colon carcinogenesis in mouse models

    Rayko Evstatiev; Adam Cervenka; Tina Austerlitz et al.

    Scientific Reports, Vol. 11 No. 1 · 2021 · English · DOAJ Scopus

    Abstract Inflammatory bowel disease is a group of conditions with rising incidence caused by genetic and environmental factors including diet. The chelator ethylenediaminetetraacetate (EDTA) is widely used by the food and pharmaceutical industry among numerous other applications, leading to a…

  4. Journal Article

    Archaea influence composition of endoscopically visible ileocolonic biofilms

    Elisabeth Orgler; Maximilian Baumgartner; Stefanie Duller et al.

    Gut Microbes, Vol. 16 No. 1 · 2024 · English · DOAJ Scopus

    The gut microbiota has been implicated as a driver of irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Recently we described, mucosal biofilms, signifying alterations in microbiota composition and bile acid (BA) metabolism in IBS and ulcerative colitis (UC). Luminal oxygen…

  5. Journal Article

    Prevalence of dysphagia and eosinophilic esophagitis in patients with inflammatory bowel disease or type 2 inflammation: a cross-sectional multicenter screening study

    Martin Bäuerle; Jurij Maurer; Jagoda Pokryszka et al.

    Therapeutic Advances in Gastroenterology, Vol. 19 · 2026 · English · DOAJ Scopus

    Background: Eosinophilic esophagitis (EoE) is a chronic, type-2 inflammation-driven disease causing dysphagia. Although patients with other type-2 inflammatory diseases (type-2 ID) or inflammatory bowel disease (IBD) may have an increased risk of EoE, there is limited information about the…